IMPROVEMENT OF COMPLEX TREATMENT OF HERPETIC STOMATITIS

Аннотация

The oral mucosal disease treatment problem is one of the urgent tasks of practical dentistry. Despite the achievements of modern science, the effectiveness of most drugs and methods of treatment of CO remains at an insufficient level. It is important to take into account that with a sufficiently effective drug, it is very important to choose the optimal dosage for each patient individually and assess the pharmacodynamic properties of the drug during treatment. At this time, sometimes, it is possible to activate or inhibit the body's adaptive mechanisms. It should also be noted that the emergence of resistance of bacteria to drugs is a constant obstacle to effective therapy of CO diseases. According to WHO, from 90 to 100% of the world's population is infected with herpes simplex viruses (type 1 and 2). This is mainly due to the introduction of new medical technologies and a significant increase in the number of patients with immunodeficiency, manifested in children by the development of an oral dysbiotic state.